Established in 1955, Bar Ilan University is one of Israel's largest universities. BIU has achieved academic and research excellence in the fields of artificial intelligence, renewable energy, bio-medicine, brain sciences, cancer, cyber security, cognitive sciences, environment, quantum technologies, medicine, archaeology, nanotechnology and advanced materials.
Seeking “Impact beyond Excellence”, BIU has created challenge-driven research centers which embrace practical research designed to change and improve the human experience. The university is also adopting innovative instructional methods, intensifying global outreach, and broadening its discourse and dialogue throughout the world.
Aim to join a consortium. Offering mice system enabling segregation of sex chromosomes and sex hormones effects to study sexual dimorphism.
Partner seeks Consortium/Coordinator
DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways
Research group developing interpretable foundation models for biomedical data. Seeking partners for Horizon Europe Cluster 1 Health 2026.
Partner seeks Consortium/Coordinator
DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
Using bioNMR we provide a detailed structural map of your biological target - invaluable in drug design and personalized medicine
Partner seeks Consortium/Coordinator
DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
Author
Principal investigator - Academia at Bar Ilan University